Nephros Inc. Drives Global Hemodiafiltration Innovation for End‑Stage Renal Care
Nephros Inc.: Innovating hemodiafiltration for end‑stage renal disease, expanding in Western Europe, and driving future growth in healthcare tech.
2 minutes to read
NEPHROS INC
Nephros Expands Hemodiafiltration Reach in Western Europe, Eyes Growth
Nephros Inc. pushes its hemodiafiltration tech into Western Europe, eyeing growth for end‑stage renal disease patients while preparing investors for Q4 2025 results.
2 minutes to read
Nephros Inc. Reports Financial Results Amid Stock Volatility and Strategic Expansion Efforts
Nephros Inc. has released its latest financial results, showing a volatile stock price and a substantial valuation gap, but the company remains committed to expanding its product reach and improving patient outcomes.
2 minutes to read